Hypothetical thought: if Aducanumab is now in Phase IV, shouldn't the revenue coming from Aducanumab related activities be accounted for as Clinical Trials revenue?
- Forums
- ASX - By Stock
- CGS
- 5 Weeks until Aducanumab PDUFA date
5 Weeks until Aducanumab PDUFA date, page-38
Featured News
Add CGS (ASX) to my watchlist
(20min delay)
|
|||||
Last
95.5¢ |
Change
-0.020(2.05%) |
Mkt cap ! $164.8M |
Open | High | Low | Value | Volume |
96.0¢ | 96.0¢ | 95.5¢ | $7.364K | 7.685K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2336 | 95.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.5¢ | 1086 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2336 | 0.955 |
4 | 31228 | 0.950 |
1 | 5466 | 0.945 |
1 | 2941 | 0.940 |
1 | 206 | 0.915 |
Price($) | Vol. | No. |
---|---|---|
0.975 | 1086 | 1 |
0.980 | 6800 | 3 |
0.990 | 14065 | 1 |
1.000 | 14065 | 1 |
1.010 | 14065 | 1 |
Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
Featured News
CGS (ASX) Chart |